1. Safety and immunogenicity of recombinant Factor VIII (RECOMBINATETM) in previously untreated patients (PUPs);Gruppo;Haemophilia,1996
2. Continuous infusion of porcine Factor VIII for the treatment of patients with Factor VIII inhibitors;Bona;Semin Hematol,1993
3. The in vitro stability of porcine Factor VIII (PFVIII) HYATE. C) and the efficacy of continuous infusion (CI) PFVIII in the treatment of patients with FVIII antibodies;Rubinger;Blood,1995
4. The use of porcine Factor VIII concentrate (HYATE:C) in the treatment of patients with inhibitor antibodies to Factor VIII;Brettler;Arch Intern Med,1989
5. Efficacy of porcine Factor VIII in the management of haemophiliacs with inhibitors;Ciavarella;Br J Haematol,1984